Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Barry Bluestein"'
Publikováno v:
Clinica Chimica Acta. 342:171-178
Background : Cardiovascular disease (CVD) is the leading cause of death in the United States. Elevations in homocysteine (Hcy) have been associated with increased risk of acute coronary syndrome, stroke and peripheral vascular disease. Increased util
Autor:
Alan H.B. Wu, Alexander Belenky, Normand Despres, Barry Bluestein, Bin Zhang, Spencer Lin, Andrew Smith
Publikováno v:
Clinica Chimica Acta. 340:163-172
Background: B-type natriuretic peptide (BNP) is a cardiac hormone that regulates hemodynamic equilibrium. In the circulation, its activity is controlled by proteolytic factors. Accurate measurement of BNP in a patient's plasma may be affected by degr
Autor:
Pradip Datta, George Parsons, Xiaoling Mai, Guohan Yang, Raymond Walsh, Peter B. Connolly, Kimberly Foster, Barry Bluestein, Se-Kyung Oh, Marcelle Orswell, Randy Reamer, Katja Tasaico, Eve H. Barlow
Publikováno v:
Clinical Biochemistry. 33:255-262
Objectives: We report the development of a fully automated, random access, chemiluminescent immunoassay, for the detection of human cardiac Troponin I (cTnI) in serum and plasma for use on the ACS:180® System. Design and methods: This assay format u
Autor:
Barry, Bluestein, Alexander, Belenky
Publikováno v:
MLO: medical laboratory observer. 40(12)
Autor:
Normand Despres, Frank H. Wians, Andrew Grant, Henry Mindicino, Ionela Gheorghiu, Carla Conarpe, Alexander Belenky, Betty Anne Wilson, Jonathan Bailey, Barry Bluestein, Kiran Thakur
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 353(1-2)
B-type natriuretic peptide (BNP) is a cardiac hormone that regulates hemodynamic equilibrium and alleviates ventricular stress. In patients with chronic heart failure, BNP levels increase in proportion to the severity of clinical symptoms and degree
Publikováno v:
Clinical Chemistry. 44:1785-1786
A recent paper by Christenson et al. (1) presented a comparative analysis of cardiac troponin I (cTnI) and T (cTnT). Their objective was to stratify patients for short-term risk of an acute coronary event on the basis of initial marker concentration
Publikováno v:
Applied Biochemistry and Biotechnology. 7:233-237